Tigecycline in-vitro susceptibility and antibiotics fitness forgram-negative pathogens

Objective was to determine the tigecycline in-vitro susceptibility ofnaive gram-negative pathogens from serious infections in Delhi, India. DuringJuly to October 2007 investigations were carried out to determine thetigecycline in vitro susceptibility of 50 consecutive gram-negative pathogensfrom serious infections at the Sant Parmanand Hospital, Delhi, India. Minimumtigecycline inhibitory concentrations were determined employing the E testmethod (AB Biodisk). Twenty-four percent of isolates were found to betigecycline resistant or partly susceptible. Susceptibility of the isolateswere lower than meropenem but similar to piperacillin-tazobactum,amoxicillin-clavulanic acid and amikacin. Tigecycline resistance wasprevalent in the gram-negative isolates from serious infections prior to itsmarketing in India. The choice of any recently marketed antibiotic for apilot treatment against serious gram-negative infections should not beautomatic. In the initial phase of its marketing, it should be evaluated inparallel with the antibiotics with excellent local susceptibility profiles.(author)